Scientific Papers

Immune response to hepatitis B vaccine among children under 5 years in Africa: a meta-analysis | Tropical Medicine and Health

Description of Image

  • Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30:2212–9. https://doi.org/10.1016/j.vaccine.2011.12.116.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Sheena BS, Hiebert L, Han H, Ippolito H, Abbasi-Kangevari M, Abbasi-Kangevari Z, et al. Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022;7:796–829. https://doi.org/10.1016/S2468-1253(22)00124-8.

    Article 

    Google Scholar
     

  • World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies, 2016–2021: actions for impact. Geneva; 2021.

  • World Health Organization. Hepatitis B 2023. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b; 2023. Accessed 13 Nov 2023.

  • Spearman CW, Afihene M, Ally R, Apica B, Awuku Y, Cunha L, et al. Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets. Lancet Gastroenterol Hepatol. 2017;2:900–9. https://doi.org/10.1016/S2468-1253(17)30295-9.

    Article 
    PubMed 

    Google Scholar
     

  • Hoffmann CJ, Thio CL. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis. 2007;7:402–9. https://doi.org/10.1016/S1473-3099(07)70135-4.

    Article 
    PubMed 

    Google Scholar
     

  • Indolfi G, Easterbrook P, Dusheiko G, Siberry G, Chang MH, Thorne C, et al. Hepatitis B virus infection in children and adolescents. Lancet Gastroenterol Hepatol. 2019;4:466–76. https://doi.org/10.1016/S2468-1253(19)30042-1.

    Article 
    PubMed 

    Google Scholar
     

  • Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis. 1995;20:992–1000. https://doi.org/10.1093/clinids/20.4.992.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • World Health Organization. Global health sector strategy on viral hepatitis 2016–2021:towards ending viral hepatitis. Geneva; 2016.

  • Maupas P, Chiron JP, Barin F, Coursaget P, Goudeau A, Perrin J, et al. Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal). Lancet. 1981;1:289–92. https://doi.org/10.1016/S0140-6736(81)91908-5.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Francis DP, Hadler SC, Thompson SE, Maynard JE, Ostrow DG, Altman N, et al. The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men. Ann Intern Med. 1982;97:362–6. https://doi.org/10.7326/0003-4819-97-3-362.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wong VC, Ip HM, Reesink HW, Lelie PN, Reerink-Brongers EE, Yeung CY, et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study. Lancet. 1984;1:921–6. https://doi.org/10.1016/S0140-6736(84)92388-2.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC, et al. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med. 1980;303:833–41. https://doi.org/10.1056/NEJM198010093031501.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis. 2002;2:395–403. https://doi.org/10.1016/S1473-3099(02)00315-8.

    Article 
    PubMed 

    Google Scholar
     

  • Chen DS. Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B. J Hepatol. 2009;50:805–16. https://doi.org/10.1016/J.JHEP.2009.01.002.

    Article 
    PubMed 

    Google Scholar
     

  • Meireles LC, Marinho RT, Van Damme P. Three decades of hepatitis B control with vaccination. World J Hepatol. 2015;7:2127–32. https://doi.org/10.4254/WJH.V7.I18.2127.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhao H, Zhou X, Zhou YH. Hepatitis B vaccine development and implementation. Hum Vaccin Immunother. 2020;16:1533–44. https://doi.org/10.1080/21645515.2020.1732166.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • World Health Organization. Hepatitis B vaccines: WHO position paper, July 2017—recommendations. Vaccine. 2019;37:223–5. https://doi.org/10.1016/j.vaccine.2017.07.046.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Breakwell L, Tevi-Benissan C, Childs L, Mihigo R, Tohme R. The status of hepatitis B control in the African region. Pan Afr Med J. 2017;27:17. https://doi.org/10.11604/pamj.supp.2017.27.3.11981.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • World Health Organization. Hepatitis B vaccination coverage. https://immunizationdata.who.int/pages/coverage/hepb.html. 2023. Accessed 14 Nov 2023.

  • World Health Organization. Introduction of HepB birth dose, https://immunizationdata.who.int/pages/vaccine-intro-by-antigen/hepb_bd.html?ISO_3_CODE=&YEAR=&CODE=AFRO. 2023. Accessed 15 Nov 2023.

  • Jack AD, Hall AJ, Maine N, Mendy M, Whittle HC. What level of hepatitis B antibody is protective? J Infect Dis. 1999;179:489–92. https://doi.org/10.1086/314578.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zuckerman JN. Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines. J Med Virol. 2006;78:169–77. https://doi.org/10.1002/JMV.20524.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Van Den EC, Marano C, Van AA, Bunge EM, De ML. The immunogenicity and safety of GSK’s recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience. Expert Rev Vaccines. 2017;16:811–32. https://doi.org/10.1080/14760584.2017.1338568.

    Article 
    CAS 

    Google Scholar
     

  • Yang S, Tian G, Cui Y, Ding C, Deng M, Yu C, et al. Factors influencing immunologic response to hepatitis B vaccine in adults. Sci Rep. 2016;6:27251. https://doi.org/10.1038/srep27251.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Fan W, Chen XF, Shen C, Guo ZR, Dong C. Hepatitis B vaccine response in obesity: a meta-analysis. Vaccine. 2016;34:4835–41. https://doi.org/10.1016/J.VACCINE.2016.08.027.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Fisman DN, Agrawal D, Leder K. Effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis. 2002;35:1368–75. https://doi.org/10.1086/344271.

    Article 
    PubMed 

    Google Scholar
     

  • Sangare L, Manhart L, Zehrung D, Wang CC. Intradermal hepatitis B vaccination: a systematic review and meta-analysis. Vaccine. 2009;27:1777–86. https://doi.org/10.1016/J.VACCINE.2009.01.043.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Wood RC, MacDonald KL, White KE, Hedberg CW, Hanson M, Osterholm MT. Risk factors for lack of detectable antibody following hepatitis B vaccination of minnesota health care workers. JAMA. 1993;270:2935–9. https://doi.org/10.1001/JAMA.1993.03510240047030.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Kubba AK, Taylor P, Graneek B, Strobel S. Non-responders to hepatitis B vaccination: a review. Commun Dis Public Health. 2003;6:106–12.

    CAS 
    PubMed 

    Google Scholar
     

  • Hollinger BF. Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations. Am J Med. 1989;87:36S-40S. https://doi.org/10.1016/0002-9343(89)90530-5.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Schillie SF, Spradling PR, Murphy TV. Immune Response of hepatitis B vaccine among persons with diabetes. Diabetes Care. 2012;35:2690–7. https://doi.org/10.2337/DC12-0312.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Opri R, Veneri D, Mengoli C, Zanoni G. Immune response to Hepatitis B vaccine in patients with celiac disease: a systematic review and meta-analysis. Hum Vaccin Immunother. 2015;11:2800–5. https://doi.org/10.1080/21645515.2015.1069448.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Tian Y, Hua W, Wu Y, Zhang T, Wang W, Wu H, et al. Immune response to hepatitis B virus vaccine among people living with HIV: a meta-analysis. Front Immunol. 2021;12: 745541. https://doi.org/10.3389/FIMMU.2021.745541.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Saco TV, Strauss AT, Ledford DK. Hepatitis B vaccine nonresponders: possible mechanisms and solutions. Ann Allergy Asthma Immunol. 2018;121:320–7. https://doi.org/10.1016/J.ANAI.2018.03.017.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Walayat S, Ahmed Z, Martin D, Puli S, Cashman M, Dhillon S. Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine. World J Hepatol. 2015;7:2503–9. https://doi.org/10.4254/WJH.V7.I24.2503.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • David MC, Ha SH, Paynter S, Lau C. A systematic review and meta-analysis of management options for adults who respond poorly to hepatitis B vaccination. Vaccine. 2015;33:6564–9. https://doi.org/10.1016/J.VACCINE.2015.09.051.

    Article 
    PubMed 

    Google Scholar
     

  • Di Lello FA, Martínez AP, Flichman DM. Insights into induction of the immune response by the hepatitis B vaccine. World J Gastroenterol. 2022;28:4249–62. https://doi.org/10.3748/WJG.V28.I31.4249.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lee JH, Hong S, Im JH, Lee JS, Baek JH, Kwon HY. Systematic review and meta-analysis of immune response of double dose of hepatitis B vaccination in HIV-infected patients. Vaccine. 2020;38:3995–4000. https://doi.org/10.1016/J.VACCINE.2020.04.022.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Rahmani A, Montecucco A, Kusznir Vitturi B, Debarbieri N, Dini G, Durando P. Long-term effectiveness of hepatitis B Vaccination in the protection of healthcare students in highly developed countries: a systematic review and meta-analysis. Vaccines. 2022;10:1841. https://doi.org/10.3390/VACCINES10111841.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Mahmood S, Shah KU, Khan TM. Immune persistence after infant hepatitis-B vaccination: a systematic review and meta-Analysis. Sci Rep. 2018;8:12550. https://doi.org/10.1038/s41598-018-30512-8.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Jiang H-Y, Wang S-Y, Deng M, Li Y-C, Ling Z-X, Shao L, et al. Immune response to hepatitis B vaccination among people with inflammatory bowel diseases: a systematic review and meta-analysis. Vaccine. 2017;35:2633–41. https://doi.org/10.1016/J.VACCINE.2017.03.080.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Schillie SF, Murphy TV. Seroprotection after recombinant hepatitis B vaccination among newborn infants: a review. Vaccine. 2013;31:2506–16. https://doi.org/10.1016/J.VACCINE.2012.12.012.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Moher D, Liberati A, Tetzlaff J, Altman DG, Group TP. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med. 2009;6: e1000097. https://doi.org/10.1371/journal.pmed.1000097.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Thomas BH, Ciliska D, Dobbins M, Micucci S. A process for systematically reviewing the literature: providing the research evidence for public health nursing interventions. Worldviews Evid-based Nurs. 2004;1:176–84. https://doi.org/10.1111/J.1524-475X.2004.04006.X.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health. 2014;72:39. https://doi.org/10.1186/2049-3258-72-39.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Miller JJ. The inverse of the freeman-tukey double arcsine transformation. Am Stat. 1978;32:138. https://doi.org/10.1080/00031305.1978.10479283.

    Article 

    Google Scholar
     

  • DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88. https://doi.org/10.1016/0197-2456(86)90046-2.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58. https://doi.org/10.1002/sim.1186.

    Article 
    PubMed 

    Google Scholar
     

  • Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al. Cochrane handbook for systematic reviews of interventions version 6.2 (updated February 2021). Cochrane; 2021.

  • Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997;315:629–34. https://doi.org/10.1136/bmj.315.7109.629.

    Article 
    CAS 

    Google Scholar
     

  • Abushady EAE, Gameel MMA, Klena JD, Ahmed SF, Abdel-Wahab KSE, Fahmy SM. HBV vaccine efficacy and detection and genotyping of vaccineé asymptomatic breakthrough HBV infection in Egypt. World J Hepatol. 2011;3:147–56. https://doi.org/10.4254/WJH.V3.I6.147.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Accrombessi M, Adetola CV, Bacharou S, Dossou Y, Avokpaho E, Yakoubou A, et al. Assessment of the anti-HBs antibody response in Beninese infants following 4 doses of HBV vaccine, including administration at birth, compared to the standard 3 doses regime; a cross-sectional survey. Vaccine. 2020;38:1787–93. https://doi.org/10.1016/J.VACCINE.2019.12.031.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Anutebeh EN, Tatah L, Feteh VF, Aroke D, Assob JCN, Choukem SP. Immune response to hepatitis B vaccine following complete immunization of children attending two regional hospitals in the Southwest region of Cameroon: a cross sectional study. BMC Infect Dis. 2021;21:1205. https://doi.org/10.1186/S12879-021-06913-Y.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Apiung T, Ndanu TA, Mingle JA, Sagoe KW. Hepatitis B virus surface antigen and antibody markers in children at a major paediatric hospital after the pentavalent DTP-HBV-Hib vaccination. Ghana Med J. 2017;51:13–9. https://doi.org/10.4314/GMJ.V51I1.3.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Aspinall S, Kocks D. Immunogenicity of a lowcost hepatitis Bvaccine in the South African Expanded Programme on Immunisation. South African Med J. 1998;88:36–9.

    CAS 

    Google Scholar
     

  • Aspinall S, Traynor D, Bedford P, Hartmann K. Lot-to-lot consistency study of the fully liquid pentavalent DTwP-HepB-Hib vaccine Quinvaxem (®) demonstrating clinical equivalence, suitability of the vaccine as a booster and concomitant administration with measles vaccine. Hum Vaccin Immunother. 2012;8:1109–18. https://doi.org/10.4161/HV.21095.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Baroncelli S, Galluzzo CM, Liotta G, Andreotti M, Orlando S, Ciccacci F, et al. HIV-exposed infants with EBV infection have a reduced persistence of the immune response to the HBV vaccine. AIDS Res Ther. 2021;18:48. https://doi.org/10.1186/S12981-021-00375-7.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Coursaget P, Bringer L, Sarr G, Bourdil C, Fritzell B, Blondeau C, et al. Comparative immunogenicity in children of mammalian cell-derived recombinant hepatitis B vaccine and plasma-derived hepatitis B vaccine. Vaccine. 1992;10:379–82. https://doi.org/10.1016/0264-410X(92)90067-T.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • El-Asheer OM, Darwish MM, Abdou MA, Saad K. Immunogenicity of recombinant hepatitis B vaccine among routinely vaccinated healthy and chronically ill children in Assiut, Upper Egypt. Gastroenterol Res. 2015;8:222–7. https://doi.org/10.14740/GR636E.

    Article 

    Google Scholar
     

  • Fortuin M, Chotard J, Jack AD, Maine NP, Mendy M, Hall AJ, et al. Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation. Lancet. 1993;341:1129–32. https://doi.org/10.1016/0140-6736(93)93137-P.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Hodgson A, Forgor AA, Chandramohan D, Reed Z, Binka F, Bevilacqua C, et al. A phase II, randomized study on an investigational DTPw-HBV/Hib-MenAC conjugate vaccine administered to infants in Northern Ghana. PLoS ONE. 2008;3: e2159. https://doi.org/10.1371/JOURNAL.PONE.0002159.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Koen A, Madhi S, Lyabis O, Vidor E, Cowper B, Marais T, et al. Immunogenicity and safety of a hexavalent pediatric vaccine in HIV-exposed infected and uninfected infants in Republic of South Africa. Hum Vaccin Immunother. 2021;17:1770–8. https://doi.org/10.1080/21645515.2020.1839289.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Madhi SA, Cutland C, Jones S, Groome M, Ortiz E. Immunogenicity and safety of an acellular pertussis, diphtheria, tetanus, inactivated poliovirus, Hib-conjugate combined vaccine (Pentaxim) and monovalent hepatitis B vaccine at 6, 10 and 14 weeks of age in infants in South Africa. S Afr Med J. 2011;101:126–31. https://doi.org/10.7196/SAMJ.4401.

    Article 
    PubMed 

    Google Scholar
     

  • Madhi SA, Mitha I, Cutland C, Groome M, Santos-Lima E. Immunogenicity and safety of an investigational fully liquid hexavalent combination vaccine versus licensed combination vaccines at 6, 10, and 14 weeks of age in healthy South African infants. Pediatr Infect Dis J. 2011;30:e68-74. https://doi.org/10.1097/INF.0B013E31820B93D2.

    Article 
    PubMed 

    Google Scholar
     

  • Magoni M, Ekra KD, Aka LN, Sita KS, Kanga K. Effectiveness of hepatitis-B vaccination in Ivory Coast: the case of the Grand Bassam health district. Ann Trop Med Parasitol. 2009;103:519–27. https://doi.org/10.1179/136485909X451816.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Mancinelli S, Pirillo MF, Liotta G, Andreotti M, Mphwere R, Amici R, et al. Antibody response to hepatitis B vaccine in HIV-exposed infants in Malawi and correlation with HBV infection acquisition. J Med Virol. 2018;90:1172–6. https://doi.org/10.1002/JMV.25049.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Mbuthia JK, Kabera BM, Karuga R, Ivui G, Mainye S, Chanzu NM, et al. A cross-sectional study to compare hepatitis B immunity in HIV-infected and HIV-uninfected Kenyan children after primary hepatitis b immunization. Pediatr Infect Dis J. 2018;37:e214–5. https://doi.org/10.1097/INF.0000000000001902.

    Article 
    PubMed 

    Google Scholar
     

  • Metodi J, Aboud S, Mpembeni R, Munubhi E. Immunity to hepatitis B vaccine in Tanzanian under-5 children. Ann Trop Paediatr. 2010;30:129–36. https://doi.org/10.1179/146532810X12703902516167.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Newton S, Owusu-Agyei S, Ampofo W, Zandoh C, Adjuik M, Adjei G, et al. Vitamin A supplementation enhances infants’ immune responses to hepatitis B vaccine but does not affect responses to Haemophilus influenzae type b vaccine. J Nutr. 2007;137:1272–7. https://doi.org/10.1093/JN/137.5.1272.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Nlend AEN, Nguwoh PS, Ngounouh CT, Tchidjou HK, Pieme CA, Otélé JM, et al. HIV-Infected or -exposed children exhibit lower immunogenicity to hepatitis B vaccine in Yaoundé, Cameroon: An appeal for revised policies in tropical settings? PLoS ONE. 2016;11: e0161714. https://doi.org/10.1371/JOURNAL.PONE.0161714.

    Article 

    Google Scholar
     

  • Ouedraogo HG, Kouanda S, Tiendrebeogo S, Liestman B, Tarnagda G, Bationo F, et al. Immune and Hepatitis B virus (HBV) infection status among children receiving hepatitis B immunization in Ouagadougou, Burkina Faso. J Pediatr Infect Dis. 2013;8:167–73. https://doi.org/10.3233/JPI-130399/BIB.

    Article 

    Google Scholar
     

  • Rey-Cuille MA, Seck A, Njouom R, Chartier L, Sow HD, Mamadou BA, et al. Low immune response to hepatitis B vaccine among children in Dakar Senegal. PLoS ONE. 2012;7: e38153. https://doi.org/10.1371/JOURNAL.PONE.0038153.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Salama II, Sami SM, Said ZNA, El-Sayed MH, El Etreby LA, Rabah TM, et al. Effectiveness of hepatitis B virus vaccination program in Egypt: multicenter national project. World J Hepatol. 2015;7:2418–26. https://doi.org/10.4254/WJH.V7.I22.2418.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Schoub BD, Matai U, Singh B, Blackburn NK, Levin JB. Universal immunization of infants with low doses of a low-cost, plasma-derived hepatitis B vaccine in South Africa. Bull World Health Organ. 2002;80:277–81.

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Shindano TA, Mbusa RK, Kabamba BM, Fiasse R, Horsmans Y. Immunisation after hepatitis B polyvalent vaccination among children in South Kivu Province, Democratic Republic of the Congo. S Afr Med J. 2019;109:319–22. https://doi.org/10.7196/SAMJ.2019.V109I5.12819.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Simani OE, Izu A, Violari A, Cotton MF, Van Niekerk N, Adrian PV, et al. Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy. AIDS. 2014;28:531–41. https://doi.org/10.1097/QAD.0000000000000127.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Tsebe KV, Burnett RJ, Hlungwani NP, Sibara MM, Venter PA, Mphahlele MJ. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds. Vaccine. 2001;19:3919–26. https://doi.org/10.1016/S0264-410X(01)00120-7.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Valéa I, Adjei S, Usuf E, Traore O, Ansong D, Tinto H, et al. Immune response to the hepatitis B antigen in the RTS, S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: a randomized controlled trial. Hum Vaccin Immunother. 2018;14:1489–500. https://doi.org/10.1080/21645515.2018.1442996.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Whittle HC, Inskip H, Hall AJ, Mendy M, Downes R, Hoare S. accination against hepatitis B and protection against chronic viral carriage in The Gambia. Lancet. 1991;337:747–50. https://doi.org/10.1016/0140-6736(91)91367-4.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Najafi F, Sayehmiri K, Najafi R. Efficacy of hepatitis B vaccination in under five-year-old children in Iran: a systematic review and meta-analysis study. Hepat Mon. 2018;18: e65385. https://doi.org/10.5812/HEPATMON.65385.

    Article 

    Google Scholar
     

  • Le MH, Yeo YH, So S, Gane E, Cheung RC, Nguyen MH. Prevalence of hepatitis B vaccination coverage and serologic evidence of immunity among US-born children and adolescents from 1999 to 2016. JAMA Netw Open. 2020;3: e2022388. https://doi.org/10.1001/JAMANETWORKOPEN.2020.22388.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Alssamei FAA, Al-Sonboli NA, Alkumaim FA, Alsayaad NS, Al-Ahdal MS, Higazi TB, et al. Assessment of immunization to hepatitis b vaccine among children under five years in rural areas of Taiz, Yemen. Hepat Res Treat. 2017;2017:2131627. https://doi.org/10.1155/2017/2131627.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Huzly D, Schenk T, Jilg W, Neumann-Haefelin D. Comparison of nine commercially available assays for quantification of antibody response to hepatitis B virus surface antigen. J Clin Microbiol. 2008;46:1298–306. https://doi.org/10.1128/JCM.02430-07.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Madiyal M, Sagar S, Vishwanath S, Banerjee B, Kalwajeeshwara V, Chawla K. Comparing assay performance of ELISA and chemiluminescence immunoassay in detecting antibodies to hepatitis B surface antigen. J Clin Diagn Res. 2016;10:DC22–5. https://doi.org/10.7860/JCDR/2016/24108.8921.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Wanlapakorn N, Pruetarat N, Sarawanangkoor N, Phanphanit K, Srimuan D, Thatsanathorn T, et al. Immunogenicity of the pentavalent DTwP-HB-Hib vaccine (Shan-5) used in the Thai Expanded Program on Immunization compared to the hexavalent DTaP-HB-Hib-IPV and DTwP-HB-Hib (Quinvaxem) vaccines administered to infants at 2, 4, 6 months of age. Vaccine. 2023;41:3855–61. https://doi.org/10.1016/J.VACCINE.2023.05.014.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Lee LY, Chan SM, Ong C, Aw M, Wong F, Saw S, et al. Comparing monovalent and combination hepatitis B vaccine outcomes in children delivered by mothers with chronic hepatitis B. J Paediatr Child Health. 2019;55:327–32. https://doi.org/10.1111/JPC.14194.

    Article 
    PubMed 

    Google Scholar
     

  • Anderson S, Harper LM, Dionne-Odom J, Halle-Ekane G, Tita ATN. A decision analytic model for prevention of hepatitis B virus infection in Sub-Saharan Africa using birth-dose vaccination. Int J Gynaecol Obstet. 2018;141:126–32. https://doi.org/10.1002/IJGO.12434.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Solomon-Rakiep T, Olivier J, Amponsah-Dacosta E. Weak adoption and performance of hepatitis B birth-dose vaccination programs in Africa: time to consider systems complexity?—A scoping review. Trop Med Infect Dis. 2023;8:474. https://doi.org/10.3390/TROPICALMED8100474.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • World Health Organization. Preventing perinatal hepatitis B virus transmission: a guide for introducing and strengthening hepatitis B birth dose vaccination. Geneva; 2015.

  • Boisson A, Goel V, Yotebieng M, Parr JB, Fried B, Thompson P, et al. Implementation approaches for introducing and overcoming barriers to hepatitis B birth-dose vaccine in sub-Saharan Africa. Glob Health Sci Pract. 2022;10: e2100277. https://doi.org/10.9745/GHSP-D-21-00277.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Irungu E, Mugo N, Ngure K, Njuguna R, Celum C, Farquhar C, et al. Immune response to hepatitis B virus vaccination among HIV-1 infected and uninfected adults in Kenya. J Infect Dis. 2013;207:402–10. https://doi.org/10.1093/INFDIS/JIS695.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Nie L, Hua W, Liu X, Pang X, Guo C, Zhang W, et al. Associated factors and immune response to the hepatitis B vaccine with a standard schedule: a prospective study of people with HIV in China. Vaccines. 2023;11:921. https://doi.org/10.3390/VACCINES11050921.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zimmermann P, Curtis N. Factors that influence the immune response to vaccination. Clin Microbiol Rev. 2019;32:e00084-e118. https://doi.org/10.1128/CMR.00084-18.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Goncalves L, Albarran B, Salmen S, Borges L, Fields H, Montes H, et al. The nonresponse to hepatitis B vaccination is associated with impaired lymphocyte activation. Virology. 2004;326:20–8. https://doi.org/10.1016/j.virol.2004.04.042.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Salama II, Sami SM, Said ZN, Salama SI, Rabah TM, Abdel-Latif GA, et al. Early and long term anamnestic response to HBV booster dose among fully vaccinated Egyptian children during infancy. Vaccine. 2018;36:2005–11. https://doi.org/10.1016/J.VACCINE.2018.02.103.

    Article 
    PubMed 

    Google Scholar
     

  • Simons BC, Spradling PR, Bruden DJT, Zanis C, Case S, Choromanski TL, et al. A longitudinal hepatitis B vaccine cohort demonstrates long-lasting hepatitis B virus (HBV) cellular immunity despite loss of antibody against HBV surface antigen. J Infect Dis. 2016;214:273–80. https://doi.org/10.1093/INFDIS/JIW142.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bruce MG, Bruden D, Hurlburt D, Zanis C, Thompson G, Rea L, et al. Antibody levels and protection after hepatitis b vaccine: results of a 30-year follow-up study and response to a booster dose. J Infect Dis. 2016;214:16–22. https://doi.org/10.1093/INFDIS/JIV748.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis. 2011;53:68–75. https://doi.org/10.1093/CID/CIR270.

    Article 
    PubMed 

    Google Scholar
     

  • Whitaker JA, Rouphael NG, Edupuganti S, Lai L, Mulligan MJ. Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1. Lancet Infect Dis. 2012;12:966–76. https://doi.org/10.1016/S1473-3099(12)70243-8.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Vargas JI, Jensen D, Martínez F, Sarmiento V, Peirano F, Acuña P, et al. Comparative efficacy of a high-dose vs standard-dose hepatitis B revaccination schedule among patients with HIV: a randomized clinical trial. JAMA Netw Open. 2021;4: e2120929. https://doi.org/10.1001/JAMANETWORKOPEN.2021.20929.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Pattyn J, Hendrickx G, Vorsters A, Van Damme P. Hepatitis B vaccines. J Infect Dis. 2021;224:S343–51. https://doi.org/10.1093/INFDIS/JIAA668.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Koc ÖM, van Oorschot E, Brandts L, Oude LA. Timing of primary three-dose hepatitis B vaccination and postvaccination serologic testing among a large cohort of healthy adults. J Med Virol. 2022;94:4433–9. https://doi.org/10.1002/JMV.27848.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Huang H, Zhang X, Luo Y, Chen J, Feng J, Dai Y, et al. The optimal interval for post-vaccination serological test in infants born to mothers with positive hepatitis B surface antigen. Hum Vaccin Immunother. 2021;17:5585–9. https://doi.org/10.1080/21645515.2021.1992213.

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Description of Image

    Source link